As financial pressures and a search for engagement redefine retirement, a new wave of seniors is turning to flexible, low-barrier side gigs. From online tutoring to pet care, these roles leverage lifelong skills without requiring prior formal experience.
CrossCurve's cross-chain bridge was exploited on February 2, leading to an estimated $3 million loss. The incident underscores the recurring security challenges within decentralized finance's bridging infrastructure.
A $100 investment in Nvidia stock a decade ago would now be worth over $27,000, illustrating one of the most remarkable growth stories in modern market history, driven by the company's pivotal role in the AI revolution.
Despite posting robust year-over-year growth, Brown & Brown's Q4 revenue miss triggered a sharp sell-off. The earnings call revealed deeper pressures, from integration challenges and talent poaching to market normalization, setting the stage for a pivotal 2024.
Boston Scientific's latest earnings beat and raised guidance, fueled by strong demand for its electrophysiology devices, signal a strategic shift. The company is navigating tariff pressures while expanding margins, with major acquisitions poised to reshape its long-term profile.
The decentralized finance protocol has publicly identified wallets linked to a weekend exploit, warning of criminal and civil action if funds are not returned within 72 hours, as security firms point to a critical validation flaw.
Iranian opposition figures allege recent state media images of Supreme Leader Khamenei are a calculated display meant to bolster morale within the security apparatus, as the regime confronts domestic unrest and international pressure.
The Adecco Group's launch of a global HR and talent consulting platform under its LHH brand marks a deliberate shift towards higher-margin services. This analysis examines whether this strategic move can reshape the company's financial narrative amid ongoing margin pressures and a challenging debt profile.
Amid a brutal year for apparel stocks, Deckers Outdoor delivered a stunning earnings beat, sending shares soaring 19%. The performance of its HOKA and UGG brands, coupled with raised guidance, suggests Wall Street's pessimism may have been overblown for this long-term winner.
Despite a sharp 22% drop in cocoa sales volume and multi-year lows in cocoa futures, Barry Callebaut's (SWX:BARN) share price has rallied strongly. Analysts are divided on whether the current valuation reflects deep value or overlooks persistent headwinds in its core commodity business.
Despite reporting a record-breaking $1 billion quarter and bullish long-term guidance, SoFi Technologies' shares are under pressure, testing a key technical level. The sell-off, driven by concerns over recent capital raising, has analysts and investors debating the fintech's true value.
Kraft Heinz announces a major corporate split, separating its global sauces division from its North American grocery business, while Berkshire Hathaway begins selling down its significant stake. The moves signal a strategic pivot for the iconic food giant, raising questions about valuation, dividends, and long-term direction in a shifting consumer landscape.
While Booz Allen Hamilton's Q4 revenue fell short of expectations, robust profitability and a strategic shift toward outcome-based contracts in high-demand sectors like cybersecurity spurred investor optimism. Analysts pressed management on the sustainability of this model and the path forward in a complex funding environment.
Fueled by surging global demand for its Hoka and Ugg brands, Deckers Outdoor Corp. posted a robust third-quarter performance that surpassed expectations, driving its stock price up sharply and assuaging recent Wall Street concerns over growth sustainability.
Salesforce secures a potential 10-year, $5.6 billion IDIQ contract with the U.S. Army, a strategic win for its national security unit. Yet, analysts caution the headline figure is a ceiling, not a guarantee, with real value hinging on future task orders and AI integration.
Regeneron Pharmaceuticals is positioning its experimental obesity drug, olatorepatide, as a potential game-changer by combining significant weight loss with a dramatic reduction in 'bad' cholesterol. The company believes this dual benefit could carve out a unique niche in the competitive $150 billion market, currently led by Novo Nordisk and Eli Lilly.
In a sweeping decree, Burkina Faso's junta has formally dissolved the nation's political parties and seized their assets, a move analysts warn consolidates authoritarian rule and extinguishes a key pillar of democratic life amid an escalating security crisis.
The Eurozone economy expanded by 1.5% in 2025, outpacing forecasts despite ongoing trade tensions with the US, as a recovery in Germany and robust growth in Spain helped offset a slowdown in France.
At its Analyst Day, Korro Bio detailed its lead candidate KRRO-121, an RNA-editing therapeutic designed to tackle hyperammonemia in urea cycle disorders and hepatic encephalopathy by stabilizing a key liver enzyme, positioning it as a potential paradigm shift from current burdensome treatments.
OSI Systems posts record Q2 revenue and lifts full-year EPS guidance, navigating softness in security bookings and healthcare challenges with optimism for a stronger second half.
